David R Vinson1,2,3, Drahomir Aujesky4, Geert-Jan Geersing5, Pierre-Marie Roy6. 1. The Permanente Medical Group, Oakland, CA. 2. Kaiser Permanente Division of Research, Oakland, CA. 3. Department of Emergency Medicine, Kaiser Permanente Sacramento Medical Center, CA. 4. Department of General Internal Medicine, Inselspital, Bern University Hospital, University of Bern, Switzerland. 5. Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, the Netherlands. 6. Emergency Department, Centre Hospitalier Universitaire, UMR (CNRS 6015 - INSERM 1083) Institut Mitovasc, Université d'Angers, France.
Abstract
INTRODUCTION: The evidence for outpatient management of hemodynamically stable, low-risk patients with acute symptomatic pulmonary embolism (PE) is mounting. Guidance in identifying patients who are eligible for outpatient (ambulatory) care is available in the literature and society guidelines. Less is known about who can identify patients eligible for outpatient management and in what clinical practice settings. OBJECTIVE: To answer the question, "Can primary care do this?" (provide comprehensive outpatient management of low-risk PE). METHODS: We undertook a narrative review of the literature on the outpatient management of acute PE focusing on site of care. We searched the English-language literature in PubMed and Embase from January 1, 1950, through July 15, 2019. RESULTS: We identified 26 eligible studies. We found no studies that evaluated comprehensive PE management in a primary care clinic or general practice setting. In 19 studies, the site-of-care decision making occurred in the Emergency Department (or after a short period of supplemental observation) and in 7 studies the decision occurred in a specialty clinic. We discuss the components of care involved in the diagnosis, outpatient eligibility assessment, treatment, and follow-up of ambulatory patients with acute PE. DISCUSSION: We see no formal reason why a trained primary care physician could not provide comprehensive care for select patients with low-risk PE. Leading obstacles include lack of ready access to advanced pulmonary imaging and the time constraints of a busy outpatient clinic. CONCLUSION: Until studies establish safe parameters of such a practice, the question "Can primary care do this?" must remain open.
INTRODUCTION: The evidence for outpatient management of hemodynamically stable, low-risk patients with acute symptomatic pulmonary embolism (PE) is mounting. Guidance in identifying patients who are eligible for outpatient (ambulatory) care is available in the literature and society guidelines. Less is known about who can identify patients eligible for outpatient management and in what clinical practice settings. OBJECTIVE: To answer the question, "Can primary care do this?" (provide comprehensive outpatient management of low-risk PE). METHODS: We undertook a narrative review of the literature on the outpatient management of acute PE focusing on site of care. We searched the English-language literature in PubMed and Embase from January 1, 1950, through July 15, 2019. RESULTS: We identified 26 eligible studies. We found no studies that evaluated comprehensive PE management in a primary care clinic or general practice setting. In 19 studies, the site-of-care decision making occurred in the Emergency Department (or after a short period of supplemental observation) and in 7 studies the decision occurred in a specialty clinic. We discuss the components of care involved in the diagnosis, outpatient eligibility assessment, treatment, and follow-up of ambulatory patients with acute PE. DISCUSSION: We see no formal reason why a trained primary care physician could not provide comprehensive care for select patients with low-risk PE. Leading obstacles include lack of ready access to advanced pulmonary imaging and the time constraints of a busy outpatient clinic. CONCLUSION: Until studies establish safe parameters of such a practice, the question "Can primary care do this?" must remain open.
Authors: Katelyn W Sylvester; Clara Ting; Andrea Lewin; Peter Collins; John Fanikos; Samuel Z Goldhaber; Jean M Connors Journal: J Thromb Thrombolysis Date: 2018-02 Impact factor: 2.300
Authors: Huyen A Tran; Harry Gibbs; Eileen Merriman; Jennifer L Curnow; Laura Young; Ashwini Bennett; Sanjeev D Chunilal; Chris M Ward; Ross Baker; Harshal Nandurkar Journal: Med J Aust Date: 2019-02-10 Impact factor: 7.738
Authors: Philip S Wells; David R Anderson; Marc A Rodger; Melissa A Forgie; Peggy Florack; Donna Touchie; Beverly Morrow; Lisa Gray; Keith O'Rourke; George Wells; Judy Kovacs; Michael J Kovacs Journal: Arch Intern Med Date: 2005-04-11
Authors: David Jiménez; Drahomir Aujesky; Lisa Moores; Vicente Gómez; José Luis Lobo; Fernando Uresandi; Remedios Otero; Manuel Monreal; Alfonso Muriel; Roger D Yusen Journal: Arch Intern Med Date: 2010-08-09
Authors: Hannah C Kulka; Andreas Zeller; Jürgen Fornaro; Walter A Wuillemin; Stavros Konstantinides; Michael Christ Journal: Dtsch Arztebl Int Date: 2021-09-17 Impact factor: 5.594
Authors: David R Vinson; Erik R Hofmann; Elizabeth J Johnson; Suresh Rangarajan; Jie Huang; Dayna J Isaacs; Judy Shan; Karen L Wallace; Adina S Rauchwerger; Mary E Reed; Dustin G Mark Journal: J Gen Intern Med Date: 2022-01-12 Impact factor: 6.473
Authors: Dayna J Isaacs; Elizabeth J Johnson; Erik R Hofmann; Suresh Rangarajan; David R Vinson Journal: Medicine (Baltimore) Date: 2020-11-06 Impact factor: 1.817
Authors: Pierre-Marie Roy; Andrea Penaloza; Olivier Hugli; Frederikus A Klok; Armelle Arnoux; Antoine Elias; Francis Couturaud; Luc-Marie Joly; Raphaëlle Lopez; Laura M Faber; Marie Daoud-Elias; Benjamin Planquette; Jérôme Bokobza; Damien Viglino; Jeannot Schmidt; Henry Juchet; Isabelle Mahe; Frits Mulder; Magali Bartiaux; Rosen Cren; Thomas Moumneh; Isabelle Quere; Nicolas Falvo; Karine Montaclair; Delphine Douillet; Charlotte Steinier; Stephan V Hendriks; Ygal Benhamou; Tali-Anne Szwebel; Gilles Pernod; Nicolas Dublanchet; François-Xavier Lapebie; Nicolas Javaud; Alexandre Ghuysen; Mustapha Sebbane; Gilles Chatellier; Guy Meyer; David Jimenez; Menno V Huisman; Olivier Sanchez Journal: Eur Heart J Date: 2021-08-31 Impact factor: 29.983